| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.935352 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240527121639 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240313e200712 onc o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-588/2007E-PDF |
|---|
| 245 | 00|aStakeholder consultation on the proposed regulatory framework for blood and blood components : |bMarch-November 2007 : consultation report / |cPolicy and Promotion Division, Centre for Policy and Regulatory Affairs, Biologics and Genetic Therapies Directorate. |
|---|
| 264 | 1|a[Ottawa] : |bBiologics and Genetic Therapies Directorate, |cDecember 2007. |
|---|
| 300 | |a1 online resource (42 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Consultation des intervenants sur le projet de cadre de réglementation du sang et des composants sanguins : mars-novembre 2007 : rapport de consultation. |
|---|
| 520 | |a"Health Canada’s blood regulatory framework under the Food and Drugs Act is being revised as one element of a renewed Canadian blood system. This initiative will address the safety of whole blood and blood components in Canada by developing updated and/or new specific regulatory requirements that reflect current technology and practices by referencing commonly accepted safety standards"--Overview, page 4. |
|---|
| 650 | 0|aBlood banks|xLaw and legislation|zCanada. |
|---|
| 650 | 0|aBlood|xTransfusion|xSafety regulations|zCanada. |
|---|
| 710 | 1 |aCanada. |bBiologics and Genetic Therapies Directorate, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tConsultation des intervenants sur le projet de cadre de réglementation du sang et des composants sanguins : |w(CaOODSP)9.938684 |
|---|
| 856 | 40|qPDF|s217 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-588-2007-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/biologics-radio-pharmaceuticals-genetic-therapies/stakeholder-consultation-proposed-regulatory-framework-blood-blood-components-march-2007-november-2007-consultation-report.html |
|---|